Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Iohexol

Iohexol

pharmaceutical raw materials
Iohexol structure

Iohexol 

structure
  • CAS No:

    66108-95-0

  • Formula:

    C19H26I3N3O9

  • Chemical Name:

    Iohexol

  • Synonyms:

    1,3-Benzenedicarboxamide,5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-;1,3-Benzenedicarboxamide,5-[acetyl(2,3-dihydroxypropyl)amino]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-;5-[Acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide;Iohexol;Exypaque;Nycodenz;Omnipaque;Omnipaque 240;Omnipaque 140;Omnipaque 350;Omnipaque 300;Omnipaque R;Accudenz;5-(N-2,3-Dihydroxypropylacetamido)-2,4,6-triiodo-N,N′-bis(2,3-dihydroxypropyl)isophthalamide.;Histodenz;Accupaque 300;Iopaque 240;Iopaque 300;Ioverin 350;1445001-72-8

  • Categories:

    Pharmaceutical Intermediates  >  Bulk Drug Intermediates

Description

Iohexol is a contrast agent.Target: OthersIohexol is a contrast agent. The osmolality of iohexol ranges from 322 mOsm/kg-approximately 1.1 times that of blood plasma-to 844 mOsm/kg, almost three times that of blood. Despite this difference, iohexol is still considered a low-osmolality contrast agent; the osmolality of older agents, such as diatrizoate, may be more than twice as high. From Wikipedia.


Solid


Iohexol is a benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic. It is an organoiodine compound and a benzenedicarboxamide.|Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.|Iohexol is a Radiographic Contrast Agent. The mechanism of action of iohexol is as a X-Ray Contrast Activity.|Iohexol is an X-ray contrast medium containing iohexol in various concentrations, from 140 to 350 milligrams of iodine per milliliter.|An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.

Iohexol Basic Attributes

821.14

821.14

266-164-2

4419T9MX03

DTXSID6023157

C65939

V08AB02|V - Various

2924299090

Characteristics

200

-3

Solid

2.2±0.1 g/cm3

174-180 °C

891.5°C at 760 mmHg

493.0±34.3 °C

1.724

7.96e-01 g/L

−20°C

LD50 in male, female rats, mice (g Iodine/kg): 15.0, 12.3, 24.3, 25.1 i.v. (Salvesen)

Safety Information

NONH for all modes of transport

1

22-24/25

CZ2205000

P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|Aggregated GHS information provided by 3 companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Toxicity

Non-ionic radiocontrast agents like iohexol are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress.

Drug Information

Iohexol ia used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures.

Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.

Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)

Small amounts are absorbed through the bladder via intravesical instillation. Following intrauterine instillation, the majority of the medium within the uterine cavity is discharged into the vagina immediately upon termination of procedure. However, any medium retained in the uterine or peritoneal cavity is absorbed systemically within 60 minutes. May not be absorbed for up to 24 hours if tubes are obstructed and dilated.|Iohexol is absorbed from cerebrospinal fluid (CSF) into the bloodstream and is eliminated by renal excretion. No significant metabolism, deiodination, or biotransformation occurs.|350-849 mL/kg|109 mL/min [Adult patients receiving 16-18 ml of iohexol (180 mgI/mL) by lumbar intrathecal injection]

Intrathecal half-life is 3.4 hours (mean). Intravascular is approximately 2 hours (with normal renal function).

Organic iodine compounds block x-rays as they pass through the body, thereby allowing body structures containing iodine to be delineated in contrast to those structures that do not contain iodine. The degree of opacity produced by these compounds is directly proportional to the total amount (concentration and volume) of the iodinated contrast agent in the path of the x-rays. After intrathecal administration into the subarachnoid space, diffusion of iohexol in the CSF allows the visualization of the subarachnoid spaces of the head and spinal canal. After intravascular administration, iohexol makes opaque those vessels in its path of flow, allowing visualization of the internal structures until significant hemodilution occurs.

Compound 545

Iohexol Use and Manufacturing

Methods of Manufacturing

Compound A (1120.5 kg, 1.50 kmol) was dissolved in a solution of KOH (140.0 kg, 2.25 kmol) in water (1232.6 kg), the temperature was controlled to below 20°C, boric acid (64.9 kg, 1.05 kmol) was equally added in a batch manner, and hydrochloric acid (30.4 kg, 0.30 kmol) was added dropwise, followed by epichlorohydrin (83.3 kg, 0.90 kmol), which was added dropwise. The pH during the reaction is 10-11. The reaction was monitored and a sample was analyzed by HPLC. The reaction was quenched by adding water (1232.6 kg) and adjusting the pH to within the range 5-6 with 18percent of hydrochloric acid when the content of Compound A was below 5percent.The reaction mixture was then decolorized with active charcoal and filtered. The filtrate contained 86.3percent of iodixanol, 7.5percent of iohexol, 2.9percent of compound A and 2.7percent of O-alkylated by-products and other impurities by HPLC analysis.Example 3 5-acetylamino-N, N'-bis (2, 3-dihydroxypropyl)-2, 4, 6-triiodoisophthalamide (Compound A) (201.5 g, 0.268 mole) was dissolved in a solution of methanol (200 mL, 1.00 mL/g Compound A) and sodium hydroxide (13.92 g, 0.348 mole, 1.30 eq) at 45°C. The mixture was cooled to 20°C and conc. hydrochloric acid (17 mL, 0.204 mole, 0.76 eq) was added followed by epichlorohydrin (8.92 g, 0.096 mole, 0.36 eq) added in one portion. After 48 hours an HPLC analysis showed the following composition: 52.1 percent iodixanol, 36.2 percent Compound A, 1.42 percent backpeaks, 0.20 percent N-acetyl cyclized iodixanol, 7.42 percent iohexol and 2.06 percent iopentol.Sodium hydroxide pellets (1.19 eq.) was dissolved in water (250 ml) and 5-acetamido-N, N'-bis(2, 3-dihydroxypropyl)-2, 4, 6-triiodo-isophthalamide (Compound A) (50 g) was added. pH was adjusted with 2 M hydrochloric acid from 12.7 to 12.2 and the mixture was cooled to 20°C followed by addition of epichlorohydrin (0.27 eq) added in three portions over 70 minutes. After 48 hours an HPLC analysis showed the following composition: 43.5 percent iodixanol, 0.8 percent backpeaks and 5.1 percent iohexol.

Uses

antibacterial

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:821.1
XLogP3:-3
Hydrogen Bond Donor Count:8
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:12
Exact Mass:820.8803
Monoisotopic Mass:820.8803
Topological Polar Surface Area:200
Heavy Atom Count:34
Complexity:653
Undefined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

This product is a commonly used contrast agent for X-ray and CT examinations, and can be used in blood vessels, spinal canals, and body cavities. Animal test results show that this product has an enhancement effect on dog liver, abdominal aorta, and CT scan images.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

Recommended Suppliers of Iohexol

Latest News on Iohexol

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.